Recent advances in cardiovascular proteomics

Journal of Proteomics

Volumn 81, Issue , 2013, Pages 3-14

  Sharma, Parveen ^a   Cosme, Jake ^a   Gramolini, Anthony O ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomarkers; Cardiac; Exosomes; MiRNA

Indexed keywords

ALDEHYDE REDUCTASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYCLOOXYGENASE 2; D DIMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRIZZLED PROTEIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 208; MICRORNA 409; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACETYLATION; ACID BASE BALANCE; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL FRACTIONATION; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHLORINATION; CONGESTIVE CARDIOMYOPATHY; ENDOTHELIUM CELL; EXOSOME; EXTRACELLULAR MATRIX; FIBROBLAST; GLYCOSYLATION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MASS SPECTROMETRY; MITOCHONDRION; MOLECULAR WEIGHT; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; PROTEOMICS; REVIEW; SYSTEMS BIOLOGY;

ANIMALS; HUMANS; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEOME; PROTEOMICS;

EID: 84877791938     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.10.026     Document Type: Review

References (143)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update. Circulation 2011, 123:e18-e209.
2. Stanley B.A., Gundrya R.L., Cottera R.J., Van Eyk J.E. Heart disease, clinical proteomics and mass spectrometry. Dis Markers 2004, 20:167-178.
3. McGregor E., Dunn M.J. Proteomics of the heart. Circ Res 2006, 98:309-321.
4. Cox B., Kotlyar M., Evangelou A.I., Ignatchenko V., Ignatchenko A., Whiteley K., et al. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol Syst Biol 2009, 5:279.
5. Rugg-Gunn Peter J., Cox Brian J., Lanner F., Sharma P., Ignatchenko V., McDonald Angela C.H., et al. Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Dev Cell 2012, 22:887-901.
6. Lundberg E., Fagerberg L., Klevebring D., Matic I., Geiger T., Cox J., et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 2010, 6:450.
7. Arab S., Gramolini A.O., Ping P., Kislinger T., Stanley B., van Eyk J., et al. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 2006, 48:1733-1741.
8. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 1975, 231-243.
9. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250:4007-4021.
10. Westbrook J.A., Wheeler J.X., Wait R., Welson S.Y., Dunn M.J. The human heart proteome: two-dimensional maps using narrow-range immobilised pH gradients. Electrophoresis 2006, 27:1547-1555.
11. Aye T.T., Scholten A., Taouatas N., Varro A., Van Veen T.A.B., Vos M.A., et al. Proteome-wide protein concentrations in the human heart. Mol Biosyst 2010, 6:1917-1927.
12. Jacquet S., Yin X., Sicard P., Clark J., Kanaganayagam G.S., Mayr M., et al. Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics 2009, 8:2687-2699.
13. Lam L., Tsoutsman T., Arthur J., Semsarian C. Differential protein expression profiling of myocardial tissue in a mouse model of hypertrophic cardiomyopathy. J Mol Cell Cardiol 2009, 48:1014-1022.
14. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2:3-10.
15. Anderson N.L., Anderson N.G. The human plasma proteome. Mol Cell Proteomics 2002, 1:845-867.
16. Franklin S., Zhang M.J., Chen H., Paulsson A.K., Mitchell-Jordan S.A., Li Y., et al. Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell Proteomics 2010, 10(1). M110.000703.
17. Rabilloud T., Kieffer S., Procaccio V., Louwagie M., Courchesne P.L., Patterson S.D., et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis 1998, 6:1006-1014.
18. Taylor S.W., Fahy E., Zhang B., Glenn G.M., Warnock D.E., Wiley S., et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 2003, 21:281-286.
19. Zhang J., Li X., Mueller M., Wang Y., Zong C., Deng N., et al. Systematic characterization of the murine mitochondrial proteome using functionally validated cardiac mitochondria. Proteomics 2008, 8:1564-1575.
20. Kim T.-Y., Wang D., Kim A.K., Lau E., Lin A.J., Liem D.A., et al. Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol Cell Proteomics 2012, 10.1074/mcp.M112.021162.
21. Mayr M., Liem D., Zhang J., Li X., Avliyakulov N.K., Yang J.I., et al. Proteomic and metabolomic analysis of cardioprotection: interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol 2009, 46:268-277.
22. Bugger H., Schwarzer M., Chen D., Schrepper A., Amorim P.A., Schoepe M., et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res 2010, 85:376-384.
23. Gregersen N., Hansen J., Palmfeldt J. Mitochondrial proteomics-a tool for the study of metabolic disorders. J Inherit Metab Dis 2012, 35:715-726.
24. Ares-Carrasco S., Picatoste B., Camafeita E., Carrasco-Navarro S., Zubiri I., Ortiz A., et al. Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPAR alpha in the associated hypertrophy. J Proteomics 2012, 75:1816-1829.
25. Y-k Iwasaki, Nishida K., Kato T., Nattel S. Atrial fibrillation pathophysiology. Circulation 2011, 124:2264-2274.
26. Goudarzi M., Ross M.M., Zhou W., Van Meter A., Deng J., Martin L.M., et al. Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation. J Proteome Res 2011, 10:3484-3492.
27. Ad N., Schneider A., Khaliulin I., Borman J.B., Schwalb H. Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: in vitro study in human myocardium. J Thorac Cardiovasc Surg 2005, 129:41-45.
28. Reilly S.N., Jayaram R., Nahar K., Antoniades C., Verheule S., Channon K.M., et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation/clinical perspective. Circulation 2011, 124:1107-1117.
29. Lau E., Wang D., Zhang J., Yu H., Lam M.P.Y., Liang X., et al. Substrate- and isoform-specific proteome stability in normal and stressed cardiac mitochondria/novelty and significance. Circ Res 2012, 110:1174-1178.
30. Savas J.N., Stein B.D., Wu C.C., Yates J.R. Mass spectrometry accelerates membrane protein analysis. Trends Biochem Sci 2011, 36:388-396.
31. Kislinger T., Cox B., Kannan A., Chung C., Hu P., Ignatchenko A., et al. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125:173-186.
32. Banfi C., Brioschi M., Wait R., Begum S., Gianazza E., Fratto P., et al. Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics 2006, 6:1976-1988.
33. Parker B.L., Palmisano G., Edwards A.V.G., White M.Y., Engholm-Keller K., Lee A., et al. Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Mol Cell Proteomics 2011, 10(8). M110.006833.
34. Chugh S., Suen C., Gramolini A. Proteomics and mass spectrometry: what have we learned about the heart?. Curr Cardiol Rev 2010, 2:124-133.
35. Hochholzer W., Morrow D.A., Giugliano R.P. Novel biomarkers in cardiovascular disease: update 2010. Am Heart J 2010, 160:583-594.
36. Ridker P.M. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 2009, 55:209-215.
37. Lowe G.D.O., Yarnell J.W.G., Rumley A., Bainton D., Sweetnam P.M. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study. Arterioscler Thromb Vasc Biol 2001, 21:603-610.
38. Reiter M., Twerenbold R., Reichlin T., Haaf P., Peter F., Meissner J., et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011, 32:1379-1389.
39. Gramolini A.O., Kislinger T., Alikhani-Koopaei R., Fong V., Thompson N.J., Isserlin R., et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics 2008, 7:519-533.
40. Gerszten R.E., Carr S.A., Sabatine M. Integration of proteomic-based tools for improved biomarkers of myocardial injury. Clin Chem 2010, 56:194-201.
41. Addona Terri A., Shi Xu, Keshishian Hasmik, Mani D.R., Burgess Michael, Gillette Michael A. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol. 2011, 29:635-643.
42. Jing L., Parker C.E., Seo D., Hines M.W., Dicheva N., Yu Y., et al. Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. Proteomics 2011, 11:2763-2776.
43. Zhang Jiang, Guy Moltu J., Norman Holly S., Chen Yi-Chen, Qingge Xu., Dong Xintong, et al. Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J Proteome Res 2011, 10:4054-4065.
44. Barallobre-Barreiro J., Didangelos A., Schoendube F.A., Drozdov I., Yin X., Fernandez-Caggiano M., et al. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury/clinical perspective. Circulation 2012, 125:789-802.
45. Schmitt J.P., Kamisago M., Asahi M., Li G.H., Ahmad F., Mende U., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003, 299:1410-1413.
46. Askevold E., Dahl C., Broch K., Aakhus S., Yndestad A., Gullestad L., et al. Circulating secreted frizzled related protein 3 (sFRP3) predicts outcome in patients with chronic heart failure. Eur J Heart Fail 2010, Supplements(2010):S6.
47. Hou Z.-h., Lu B., Gao Y., Cao H.-l., Yu F.-f., Jing N., et al. Matrix metalloproteinase-9 (MMP-9) and myeloperoxidase (MPO) levels in patients with nonobstructive coronary artery disease detected by coronary computed tomographic angiography. Acad Radiol 2012, 10.1016/j.acra.2012.07.014.
48. Tang W.H.W., Wu Y., Nicholls S.J., Hazen S.L. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. Clin Chem 2011, 57:33-39.
49. von Leitner E.-C., Klinke A., Atzler D., Slocum J.L., Lund N., Kielstein J.T., et al. Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase/clinical perspective. Circulation 2011, 124:2735-2745.
50. Geoghegan K.F., Varghese A.H., Feng X., Bessire A.J., Conboy J.J., Ruggeri R.B., et al. Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS4). Biochemistry 2012, 51:2065-2077.
51. Heslop C.L., Frohlich J.J., Hill J.S. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010, 55:1102-1109.
52. Meuwese M.C., Stroes E.S.G., Hazen S.L., van Miert J.N., Kuivenhoven J.A., Schaub R.G., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk prospective population study. J Am Coll Cardiol 2007, 50:159-165.
53. Ndrepepa G., Braun S., Mehilli J., Von Beckerath N., Schömig A., Kastrati A. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 2008, 38:90-96.
54. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286:2136-2142.
55. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
56. Vasilyev N., Williams T., Brennan M.-L., Unzek S., Zhou X., Heinecke J.W., et al. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 2005, 112:2812-2820.
57. Shao B., Heinecke J.W. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. J Proteomics 2011, 74:2289-2299.
58. Shao B., Pennathur S., Heinecke J.W. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J Biol Chem 2012, 287:6375-6386.
59. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
60. Raimondo F., Morosi L., Chinello C., Magni F., Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011, 11:709-720.
61. de Jong O.G., Verhaar M.C., Chen Y., Vader P., Gremmels H., Posthuma G., et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Ves 2012, 1:18396. 10.3402/jev.v1i0.18396.
62. Hergenreider E., Heydt S., Treguer K., Boettger T., Horrevoets A.J.G., Zeiher A.M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14:249-256.
63. Ji H., Erfani N., Tauro B.J., Kapp E.A., Zhu H.-J., Moritz R.L., et al. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis 2008, 29:2660-2671.
64. Waldenstrom A., Genneback N., Hellman U., Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One 2012, 7:e34653.
65. Gupta S., Knowlton A.A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Phyisol 2007, 292:H3052-H3056.
66. Lim J.W.E., Mathivanan S., Moritz R.L., Simpson R.J. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009, 6:267-283.
67. de la Cuesta F., Barderas M.G., Calvo E., Zubiri I., Maroto A.S., Darde V.M., et al. Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics 2012, 75:2960-2971.
68. Andre F., Schartz N.E.C., Movassagh M., Flament C., Pautier P., Morice P., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002, 360:295-305.
69. Choi D.-S., Lee J.-M., Park G.W., Lim H.-W., Bang J.Y., Kim Y.-K., et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 2007, 6:4646-4655.
70. Welton J.L., Khanna S., Giles P.J., Brennan P., Brewis I.A., Staffurth J., et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 2010, 9:1324-1338.
71. Palazzolo G., Albanese N.N., Di Cara G., Gygax D., Vittorelli M.L., Pucci-Minafra I.D.A. Proteomic analysis of exosome-like vesicles derived from breast cancer cells. Anticancer Res 2012, 32:847-860.
72. Hosseini-Beheshti E., Pham S., Adomat H., Li N., Guns E.S. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 2012, 11:863-885.
73. Little K.M., Smalley D.M., Harthun N.L., Ley K. The plasma microparticle proteome. Semin Thromb Hemost 2010, 36:845-856.
74. Théry C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2001, 68:2667-2688. [John Wiley & Sons, Inc., 16].
75. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
76. Lamparski H.G., Metha-Damani A., Yao J.-Y., Patel S., Hsu D.-H., Ruegg C., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 2002, 270:211-226.
77. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
78. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease. Circ Res 2012, 110:483-495.
79. Cordes K.R., Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res 2009, 104:724-732.
80. Dangwal S., Bang C., Thum T. Novel techniques and targets in cardiovascular microRNA research. Cardiovasc Res 2012, 93:545-554.
81. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
82. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009, 55:1944-1949.
83. Abbas N.A., John R.I., Webb M.C., Kempson M.E., Potter A.N., Price C.P., et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005, 51:2059-2066.
84. Espinoza-Lewis R.A., Wang D.Z. MicroRNAs in heart development. Curr Top Dev Biol 2012, 100:279-317. [Academic Press].
85. Kuwabara Y., Ono K., Horie T., Nishi H., Nagao K., Kinoshita M., et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage/clinical perspective. Circ Cardiovasc Genet 2011, 4:446-454.
86. Dewey F.E., Perez M.V., Wheeler M.T., Watt C., Spin J., Langfelder P., et al. Gene coexpression network topology of cardiac development, hypertrophy, and failure/clinical perspective. Circ Cardiovasc Genet 2011, 4:26-35.
87. Elashoff M.R., Wingrove J.A., Beineke P., Daniels S.E., Tingley W.G., Rosenberg S., et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics 2011, 4:26.
88. Azuaje F.J., Dewey F.E., Brutsaert D.L., Devaux Y., Ashley E.A., Wagner D.R. Systems-based approaches to cardiovascular biomarker discovery. Circ Cardiovasc Genet 2012, 5:360-367.
89. Bensimon A., Heck A.J.R., Aebersold R. Mass spectrometry based proteomics and network biology. Annu Rev Biochem 2012, 81:379-405.
90. Ping P., Zhang J., Pierce W.M., Bolli R. Functional proteomic analysis of protein kinase C ε signaling complexes in the normal heart and during cardioprotection. Circ Res 2001, 88:59-62.
91. Ping P. A new chapter in cardiac PKC signaling studies: searching for isoform-specific molecular targets. Focus on: isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes. Am J Physiol Cell Physiol 2003, 285:C19-C21.
92. Zhang J., Baines C.P., Zong C., Cardwell E.M., Wang G., Vondriska T.M., et al. Functional proteomic analysis of a three-tier PKCε-Akt-eNOS signaling module in cardiac protection. Am J Physiol Heart Circ Physiol 2005, 288:H954-H961.
93. Xiang F., Shi Z., Guo X., Qiu Z., Chen X., Huang F., et al. Proteomic analysis of myocardial tissue from the border zone during early stage post-infarct remodelling in rats. Eur J Heart Fail 2011, 13:254-263.
94. Gallien S., Duriez E., Crone C., Kellmann M., Moehring T., Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012, 10.1074/mcp.O112.019802.
95. Michalski A., Damoc E., Hauschild J.-P., Lange O., Wieghaus A., Makarov A., et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole orbitrap mass spectrometer. Mol Cell Proteomics 2011, 10. [M111.011015].
96. Nagaraj N., Alexander Kulak N., Cox J., Neuhauser N., Mayr K., Hoerning O., et al. System-wide perturbation analysis with nearly complete coverage of the Yeast proteome by single-shot ultra HPLC runs on a bench top orbitrap. Mol Cell Proteomics 2012, 11. [M111.013722].
97. von Mering C., Huynen M., Jaeggi D., Schmidt S., Bork P., Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 2003, 31:258-261.
98. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39:D561-D568.
99. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
100. Masoudi-Nejad A., Ansariola M., Razaghi Moghadam Kashani Z., Salehzadeh-Yazdi A., Khakabimamaghani S. CytoKavosh: a Cytoscape plug-in for finding network motifs in large biological networks. PLoS One 2012, 7:e43287.
101. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-D484.
102. Stark C., Breitkreutz B.-J., Reguly T., Boucher L., Breitkreutz A., Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006, 34:D535-D539.
103. Mueller L.N., Brusniak M.-Y., Mani D.R., Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J Proteome Res 2008, 7:51-61.
104. Walther T.C., Mann M. Mass spectrometry based proteomics in cell biology. J Cell Biol 2010, 190:491-500.
105. Cox J., Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem 2011, 80:273-299.
106. Cox B., Sharma P., Evangelou A.I., Whiteley K., Ignatchenko V., Ignatchenko A., et al. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics 2011, 10. [M111.012526].
107. Sharma P., Shathasivam T., Ignatchenko V., Kislinger T., Gramolini A.O. Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Mol Biosyst 2011, 7:1185-1196.
108. Ryan T., Sharma P., Ignatchenko A., MacLennan D.H., Kislinger T., Gramolini A.O. Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). J Biol Chem 2011, 286(19):17060-17068.
109. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
110. Zybailov B., Coleman M.K., Florens L., Washburn M.P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem 2005, 77:6218-6224.
111. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
112. Elmore J.M., Liu J., Smith B., Phinney B., Coaker G. Quantitative proteomics reveals dynamic changes in the plasma membrane during Arabidopsis immune signaling. Mol Cell Proteomics 2012, 11. [M111.014555].
113. Choe L., D'Ascenzo M., Relkin N.R., Pappin D., Ross P., Williamson B., et al. 8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics 2007, 7:3651-3660.
114. Beck F, Burkhart JM, Geiger J, Zahedi René P, Sickmann A. Robust Workflow for iTRAQ-Based Peptide and Protein Quantification Methods in Molecular Biology. 2012;893:101-13.
115. Werner T., Becher I., Sweetman G., Doce C., Savitski M.M., Bantscheff M. High-resolution enabled TMT 8-plexing. Anal Chem 2012, 84:7188-7194.
116. Dayon L., Sonderegger B., Kussmann M. Combination of gas-phase fractionation and MS3 acquisition modes for relative protein quantification with isobaric tagging. J Proteome Res 2012, 11(10):5081-5089.
117. Geiger T., Wisniewski J.R., Cox J., Zanivan S., Kruger M., Ishihama Y., et al. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat Protoc 2011, 6:147-157.
118. Wang H.-X., Kolesnikova T.V., Denison C., Gygi S.P., Hemler M.E. The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci 2011, 124:2702-2710.
119. Domanski D., Percy A.J., Yang J., Chambers A.G., Hill J.S., Freue G.V.C., et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 2012, 12:1222-1243.
120. Waldemarson S., Krogh M., Alaiya A., Kirik U., Schedvins K., Auer G., et al. Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res 2012, 11:2876-2889.
121. Hutenhain R., Soste M., Selevsek N., Rost H., Sethi A., Carapito C., et al. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med 2012, 4:142ra94.
122. Makawita S., Diamandis E.P. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry based approaches: current strategies for candidate verification. Clin Chem 2010, 56:212-222.
123. Keshishian H., Addona T., Burgess M., Mani D.R., Shi X., Kuhn E., et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009, 8:2339-2349.
124. Keshishian H., Addona T., Burgess M., Kuhn E., Carr S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007, 6:2212-2229.
125. Kuzyk M.A., Smith D., Yang J., Cross T.J., Jackson A.M., Hardie D.B., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8:1860-1877.
126. Agnetti G., Husberg C., Van Eyk J.E. Divide and conquer. Circ Res 2011, 108:512-526.
127. Husberg C., Agnetti G., Holewinski R.J., Christensen G., Van Eyk J.E. Dephosphorylation of cardiac proteins in vitro - a matter of phosphatase specificity. Proteomics 2012, 12:973-978.
128. Kohr M.J., Aponte A.M., Sun J., Wang G., Murphy E., Gucek M., et al. Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol 2011, 300:H1327-H1335.
129. Murphy E., Kohr M., Sun J., Nguyen T., Steenbergen C. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol 2012, 52:568-577.
130. Grillon J.M., Johnson K.R., Kotlo K., Danziger R.S. Non-histone lysine acetylated proteins in heart failure. Biochim Biophys Acta (BBA) - Mol Basis Dis 2012, 1822:607-614.
131. Lundby A., Lage K., Weinert Brian T., Bekker-Jensen Dorte B., Secher A., Skovgaard T. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep 2012, 2:419-431.
132. Talens R.P., Jukema J.W., Trompet S., Kremer D., Westendorp R.G.J., Lumey L.H., et al. Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. Int J Epidemiol 2012, 1:106-115.
133. Montpetit M.L., Stocker P.J., Schwetz T.A., Harper J.M., Norring S.A., Schaffer L., et al. Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci 2009, 106:16517-16522.
134. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007, 356:1140-1151.
135. Boja E.S., Phillips D., French S.A., Harris R.A., Balaban R.S. Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-orbitrap with high energy collision dissociation. J Proteome Res 2009, 8:4665-4675.
136. Lotz C., Liem D., Ping P. New frontiers in myocardial protection. J Cardiovasc Pharmacol Ther 2011, 16:285-289.
137. Phillips D., Aponte A.M., Covian R., Balaban R.S. Intrinsic protein kinase activity in mitochondrial oxidative phosphorylation complexes. Biochemistry 2011, 50:2515-2529.
138. Covian R., Balaban R.S. Cardiac mitochondrial matrix and respiratory complex protein phosphorylation. Am J Physiol Heart Circ Physiol 2012, 303(8):H940-H966.
139. Aponte A.M., Phillips D., Hopper R.K., Johnson D.T., Harris R.A., Blinova K., et al. Use of 32P to study dynamics of the mitochondrial phosphoproteome. J Proteome Res 2009, 8:2679-2695.
140. Deng N., Zhang J., Zong C., Wang Y., Lu H., Yang P., et al. Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics 2010, 10(2). M110.000117.
141. Scruggs S.B., Zong N.C., Wang D., Stefani E., Ping P. Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol 2012, 303:H9-H18.
142. Zong C., Young G.W., Wang Y., Lu H., Deng N., Drews O., et al. Two-dimensional electrophoresis based characterization of post-translational modifications of mammalian 20S proteasome complexes. Proteomics 2008, 8:5025-5037.
143. Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., et al. Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun 2012, 3:876.